Jennifer C.
- Country
- France
- Department
- Service Cardiologie
Research Overview
- Discontinuation of Beta-Blockers in Heart Failure Patients with Recovered Left Ventricular Ejection Fraction: A Non-Inferiority Study
- Assessment of Cardiac Function Evolution in Cancer Patients Undergoing PD-1 Inhibition with Nivolumab and Pembrolizumab
- Evaluation of Vicadrostat (BI 690517) and Empagliflozin Efficacy and Safety in Type 2 Diabetes, Hypertension, and Cardiovascular Disease Patients
Data & Insights
Has run more than one trial at 10 of 434 partner sites.
Specializations
Cardio-Oncology
The investigator specializes in studying the intersection of cardiac health and cancer treatment, with particular emphasis on monitoring heart function during immunotherapy treatments.
- Cardiac Function Monitoring
- Cancer Immunotherapy Effects
- Left Ventricular Assessment
Their work centers on understanding cardiac responses during PD-1 inhibition therapy.
Cancer Immunotherapy
The investigator focuses on evaluating the cardiovascular impact of immune checkpoint inhibitors, specifically examining treatments targeting the PD-1 pathway.
- PD-1 Inhibitor Therapy
- Treatment Monitoring
- Patient Safety Assessment
Their research encompasses cardiac safety profiles in cancer immunotherapy treatments.
Clinical Monitoring
The investigator's expertise extends to developing and implementing specialized monitoring protocols within dedicated cardio-oncology units.
- Cardiac Safety Protocols
- Treatment Follow-up
- Clinical Assessment Methods
Their work involves systematic cardiac function evaluation during cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.